Websites selling AMH “fertility” tests use false or misleading claims, researchers find

Tests for the anti-müllerian hormone (AMH) are being marketed as measures of fertility using claims that could lead to “misplaced anxiety or reassurance” and could change people’s plans for contraception or conception, researchers have warned.1A research team based in Australia identified 27 websites in the US, India, UK, Canada, Ireland, the Netherlands, and Australia that sold direct-to-consumer AMH tests. They said that, despite evidence that the test cannot reliably predict current or future fertility, three quarters (20) of the websites analysed stated that the test could provide insight into fertility and chances of conception.Many of the websites also claimed that the test could indicate menopause timing (20 websites; 74%) or identify women at risk of premature menopause (11; 41%).The AMH test is a blood test that can indicate the number of eggs in a woman’s ovaries and can be used to assist with female infertility planning. However, there are several…
Read Original Article: Websites selling AMH “fertility” tests use false or misleading claims, researchers find »